DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name ▲ | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0600139 | Prostate carcinoma | ACAT1 | 38 | acetyl-CoA acetyltransferase 1 | P24752 |
C0600139 | Prostate carcinoma | LGALS1 | 3956 | galectin 1 | P09382 |
C0600139 | Prostate carcinoma | LCT | 3938 | lactase | P09848 |
C0600139 | Prostate carcinoma | LGALS3 | 3958 | galectin 3 | P17931 |
C0600139 | Prostate carcinoma | LPL | 4023 | lipoprotein lipase | P06858 |
C0600139 | Prostate carcinoma | STS | 412 | steroid sulfatase | P08842 |
C0600139 | Prostate carcinoma | LTA4H | 4048 | leukotriene A4 hydrolase | P09960 |
C0600139 | Prostate carcinoma | MAG | 4099 | myelin associated glycoprotein | P20916 |
C0600139 | Prostate carcinoma | MRC1 | 4360 | mannose receptor C-type 1 | P22897 |
C0600139 | Prostate carcinoma | NCAM1 | 4684 | neural cell adhesion molecule 1 | P13591 |
C0600139 | Prostate carcinoma | NT5E | 4907 | 5'-nucleotidase ecto | P21589 |
C0600139 | Prostate carcinoma | PIK3CD | 5293 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | O00329 |
C0600139 | Prostate carcinoma | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0600139 | Prostate carcinoma | ISYNA1 | 51477 | inositol-3-phosphate synthase 1 | Q9NPH2 |
C0600139 | Prostate carcinoma | PLCG1 | 5335 | phospholipase C gamma 1 | P19174 |
C0600139 | Prostate carcinoma | PLA2G2A | 5320 | phospholipase A2 group IIA | P14555 |
C0600139 | Prostate carcinoma | PLD2 | 5338 | phospholipase D2 | O14939 |
C0600139 | Prostate carcinoma | AGK | 55750 | acylglycerol kinase | Q53H12 |
C0600139 | Prostate carcinoma | LPCAT2 | 54947 | lysophosphatidylcholine acyltransferase 2 | Q7L5N7 |
C0600139 | Prostate carcinoma | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0600139 | Prostate carcinoma | TMED9 | 54732 | transmembrane p24 trafficking protein 9 | Q9BVK6 |
C0600139 | Prostate carcinoma | ACSS2 | 55902 | acyl-CoA synthetase short chain family member 2 | Q9NR19 |
C0600139 | Prostate carcinoma | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0600139 | Prostate carcinoma | CMAS | 55907 | cytidine monophosphate N-acetylneuraminic acid synthetase | Q8NFW8 |
C0600139 | Prostate carcinoma | SPHK2 | 56848 | sphingosine kinase 2 | Q9NRA0 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024